Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Bone Marrow Transplantation|August 13, 2008
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term resultsK M Ramadan, J M Connors, A J Al-Tourah, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2015
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell TransplantationHaowei Sun, Kerry J Savage, Aly Karsan, et al.
Leukemia & Lymphoma|November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Blood|March 30, 2016
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cellsAmina Kariminia, Shernan G Holtan, Sabine Ivison, et al.
Blood Cancer Journal|March 14, 2015
The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromesK L McGraw, L M Zhang, D E Rollison, et al.
American Journal of Hematology|July 5, 2017
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systemsRena Buckstein, Enrico Balleari, Richard Wells, et al.
The Journal of Trauma and Acute Care Surgery|April 5, 2023
Early VTE prophylaxis in severe traumatic brain injury: A propensity score weighted EAST multicenter studyAsanthi M Ratnasekera, Daniel Kim, Sirivan S Seng, et al.
Injury|April 13, 2024
Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter studyAsanthi M Ratnasekera, Sirivan S Seng, Daniel Kim, et al.
Pageof 8